Search Results

There are 6469 results for: content related to: Proteomic pattern analysis discriminates among multiple sclerosis–related disorders

  1. Structural insight into RNA recognition motifs: versatile molecular Lego building blocks for biological systems

    Wiley Interdisciplinary Reviews: RNA

    Volume 3, Issue 2, March/April 2012, Pages: 229–246, Yutaka Muto and Shigeyuki Yokoyama

    Version of Record online : 25 JAN 2012, DOI: 10.1002/wrna.1107

  2. You have free access to this content
    Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein

    European Journal of Immunology

    Volume 40, Issue 10, October 2010 , Pages: 2942–2956, Christopher T. Harp, Sara Ireland, Laurie S. Davis, Gina Remington, Bonnie Cassidy, Petra D. Cravens, Olaf Stuve, Amy E. Lovett-Racke, Todd N. Eagar, Benjamin M. Greenberg, Michael K. Racke, Lindsay G. Cowell, Nitin J. Karandikar, Elliot M. Frohman and Nancy L. Monson

    Version of Record online : 1 SEP 2010, DOI: 10.1002/eji.201040516

  3. Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis

    Journal of Magnetic Resonance Imaging

    Volume 35, Issue 6, June 2012, Pages: 1300–1311, Khader M. Hasan, Indika S. Walimuni, Humaira Abid, Jerry S. Wolinsky and Ponnada A. Narayana

    Version of Record online : 12 JAN 2012, DOI: 10.1002/jmri.23539

  4. Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration

    Journal of Magnetic Resonance Imaging

    Volume 36, Issue 1, July 2012, Pages: 1–19, René M. Vigeveno, Oliver T. Wiebenga, Mike P. Wattjes, Jeroen J.G. Geurts and Frederik Barkhof

    Version of Record online : 13 JUN 2012, DOI: 10.1002/jmri.23578

  5. You have free access to this content
    Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies

    Clinical & Experimental Immunology

    Volume 175, Issue 3, March 2014, Pages: 359–372, N. Melzer and S. G. Meuth

    Version of Record online : 4 FEB 2014, DOI: 10.1111/cei.12195

  6. Periventricular lesions correlate with cortical thinning in multiple sclerosis

    Annals of Neurology

    Volume 78, Issue 4, October 2015, Pages: 530–539, Margit Jehna, Lukas Pirpamer, Michael Khalil, Siegrid Fuchs, Stefan Ropele, Christian Langkammer, Alexander Pichler, Franziska Stulnig, Hannes Deutschmann, Franz Fazekas and Christian Enzinger

    Version of Record online : 28 JUL 2015, DOI: 10.1002/ana.24461

  7. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

    Annals of Neurology

    Volume 78, Issue 5, November 2015, Pages: 801–813, Shiv Saidha, Omar Al-Louzi, John N. Ratchford, Pavan Bhargava, Jiwon Oh, Scott D. Newsome, Jerry L. Prince, Dzung Pham, Snehashis Roy, Peter van Zijl, Laura J. Balcer, Elliot M. Frohman, Daniel S. Reich, Ciprian Crainiceanu and Peter A. Calabresi

    Version of Record online : 1 OCT 2015, DOI: 10.1002/ana.24487

  8. White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome

    Magnetic Resonance in Medicine

    Volume 68, Issue 6, December 2012, Pages: 1932–1942, Efrosini Z. Papadaki, Vasileios C. Mastorodemos, Emmanouil Z. Amanakis, Konstantinos C. Tsekouras, Antonis E. Papadakis, Nikolaos D. Tsavalas, Panagiotis G. Simos, Apostolos H. Karantanas, Andreas Plaitakis and Thomas G. Maris

    Version of Record online : 24 FEB 2012, DOI: 10.1002/mrm.24194

  9. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis

    PROTEOMICS

    Volume 15, Issue 19, October 2015, Pages: 3361–3369, Ann C. Kroksveen, Jacob D. Jaffe, Elise Aasebø, Harald Barsnes, Yngvild Bjørlykke, Diego Franciotta, Hasmik Keshishian, Kjell-Morten Myhr, Jill A. Opsahl, Vincent van Pesch, Charlotte E. Teunissen, Øivind Torkildsen, Rune J. Ulvik, Heidrun Vethe, Steven A. Carr and Frode S. Berven

    Version of Record online : 8 SEP 2015, DOI: 10.1002/pmic.201400142

  10. You have free access to this content
    The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression

    The FEBS Journal

    Volume 272, Issue 9, May 2005, Pages: 2118–2131, Christophe Maris, Cyril Dominguez and Frédéric H.-T. Allain

    Version of Record online : 21 APR 2005, DOI: 10.1111/j.1742-4658.2005.04653.x

  11. An information systems design product theory for the class of integrated requirements and release management systems

    Journal of Software Maintenance and Evolution: Research and Practice

    Volume 23, Issue 6, October 2011, Pages: 443–463, Timo Käkölä, Mervi Koivulahti-Ojala and Jani Liimatainen

    Version of Record online : 3 SEP 2010, DOI: 10.1002/smr.492

  12. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype

    Human Brain Mapping

    Volume 32, Issue 10, October 2011, Pages: 1535–1543, Gianna Riccitelli, Maria A. Rocca, Elisabetta Pagani, Maria E. Rodegher, Paolo Rossi, Andrea Falini, Giancarlo Comi and Massimo Filippi

    Version of Record online : 25 AUG 2010, DOI: 10.1002/hbm.21125

  13. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing–remitting multiple sclerosis

    NMR in Biomedicine

    Volume 28, Issue 11, November 2015, Pages: 1374–1382, Ali Al-Radaideh, Olivier E. Mougin, Su-Yin Lim, I-Jun Chou, Cris S. Constantinescu and Penny Gowland

    Version of Record online : 7 SEP 2015, DOI: 10.1002/nbm.3385

  14. You have free access to this content
    Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Graziella Filippini, Cinzia Del Giovane, Laura Vacchi, Roberto D'Amico, Carlo Di Pietrantonj, Deirdre Beecher and Georgia Salanti

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD008933.pub2

  15. Human immunoglobulin G suppresses the production of matrix metalloproteinase-9 in peripheral blood mononuclear cells of patients with multiple sclerosis

    Clinical and Experimental Neuroimmunology

    Volume 6, Issue 3, August 2015, Pages: 281–288, Kazumasa Okada and Hiroaki Adachi

    Version of Record online : 4 MAY 2015, DOI: 10.1111/cen3.12214

  16. You have free access to this content
    Imaging biomarkers in multiple sclerosis

    Journal of Magnetic Resonance Imaging

    Volume 31, Issue 4, April 2010, Pages: 770–788, M. Filippi and F. Agosta

    Version of Record online : 29 MAR 2010, DOI: 10.1002/jmri.22102

  17. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis

    Human Brain Mapping

    Volume 36, Issue 5, May 2015, Pages: 1796–1807, Martijn D. Steenwijk, Marita Daams, Petra J.W. Pouwels, Lisanne J. Balk, Prejaas K. Tewarie, Jeroen J. G. Geurts, Frederik Barkhof and Hugo Vrenken

    Version of Record online : 27 JAN 2015, DOI: 10.1002/hbm.22738

  18. You have full text access to this OnlineOpen article
    Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 5, May 2015, Pages: 445–455, Yen Chih Lin, Paige Winokur, Andrew Blake, Tianxia Wu, Elena Romm and Bibiana Bielekova

    Version of Record online : 7 APR 2015, DOI: 10.1002/acn3.181

  19. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis

    Acta Neurologica Scandinavica

    Volume 121, Issue 5, May 2010, Pages: 309–314, M. M. Verbeek, E. A. Notting, B. Faas, R. Claessens-Linskens and P. J. H. Jongen

    Version of Record online : 19 NOV 2009, DOI: 10.1111/j.1600-0404.2009.01242.x

  20. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing−remitting patients but not in primary progressive patients

    European Journal of Neurology

    Volume 22, Issue 3, March 2015, Pages: 507–e35, A. Kerbrat, S. Hamonic, E. Leray, I. Tron, G. Edan, J. Yaouanq and on behalf of the West Neuroscience Network of Excellence (WENNE)

    Version of Record online : 16 DEC 2014, DOI: 10.1111/ene.12600